Catheter-directed Venous Thrombolysis
in Acute Iliofemoral Vein Thrombosis) trials, are currently underway and will likely provide further evidence
regarding the clinical utility of these strategies. We anticipate that the results of these trials will lead to guideline revisions.
The currently available evidence cannot address several
important questions. These include the optimal thrombolytic dose, the relative safety and efficacy of different thrombolytic agents and mechanical thrombectomy devices